Clinical practice. Management of an inherited predisposition to breast cancer.
about
The population genetics of the Jewish peopleDevelopments in renal pharmacogenomics and applications in chronic kidney diseaseGenetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicinePenetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.Iranian Breast Cancer Bio-Bank: the activity and challenging issues.Common genetic variants and modification of penetrance of BRCA2-associated breast cancerGenetic screening: A primer for primary care.Two decades after BRCA: setting paradigms in personalized cancer care and preventionBreast magnetic resonance imaging: are those who need it getting it?Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.Performance of first mammography examination in women younger than 40 years.Dual-energy contrast-enhanced breast tomosynthesis: optimization of beam quality for dose and image quality.Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian CancerBreast cancer susceptibility: current knowledge and implications for genetic counsellingOccult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.Genome-wide association studies of cancer.Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.An overview of hereditary breast and ovarian cancer syndrome.Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriersHeterozygous mutations in DNA repair genes and hereditary breast cancer: a question of power.Personalized medicine: new genomics, old lessonsDiscriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative womenWhen parents disclose BRCA1/2 test results: their communication and perceptions of offspring responseProspective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas.Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populManagement of breast cancer--part I.Dealing with the unexpected: consumer responses to direct-access BRCA mutation testingIdentification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto RicoGermline BRCA mutations denote a clinicopathologic subset of prostate cancer.Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testingPsychosocial Adjustment in School-age Girls With a Family History of Breast CancerPrediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United StatesA rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencingGenomic Biomarkers for Breast Cancer Risk.Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.The molecular genetics of breast cancer and targeted therapyPrevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.
P2860
Q24633199-DD11A8EF-D3D0-48AB-956B-8685826D9617Q26999279-D60E7978-062E-451B-AD69-6E6CC00E313DQ30513982-6B5493AC-D6FD-4E14-8F0F-6B5B2AEB9F92Q33338978-2395B469-7285-458E-897F-3366A16DC620Q33454439-F2BE075E-7B9A-4FD5-8BC0-B56926FD519AQ33742096-1D66B6DC-5709-4D36-AAA5-12A2C7BE7394Q33815299-680F5D43-80AB-4D7F-860B-87FCBD58E7F2Q33820594-4A479906-482E-42D7-86BD-649BD52C4548Q33840185-991EABA9-DB93-4A03-A246-31D4B838D95CQ33847327-BFF09BC0-4C8C-4147-A1A8-16410C4FB508Q33988384-FEB2DC20-233F-480F-86D8-DCE0DCCBF799Q34102679-E94B9C2C-0387-4D3E-87A2-8FBBF9987A30Q34152848-BEDBD7CE-D928-4682-A20C-E6D59A117600Q34161642-49346E17-68B3-4DDF-94DF-DC040E0F61E0Q34172655-565C99DE-58CB-4D64-8E16-10A51D446FF4Q34193988-670216CB-B3A8-4815-982B-07B1FDB758C9Q34267477-2B0B488F-AF35-40CB-BEAD-06E3356F9577Q34305000-8A43D807-35EB-4835-AB7C-5EDD0CA09DD0Q34309892-46D8817D-4F75-41F3-9A6F-149B4946959BQ34426654-A804E057-4523-4396-9FAD-61BC631DDC59Q35082635-B4A1743C-AF61-4A16-91E4-7B8DC241047AQ35846927-14E13AE4-7D78-4EF4-ADE1-497ED406B3F5Q35888415-465421DE-8A34-4375-B7AD-5F41FD9784F7Q35930061-AA8C7C41-25DF-449B-9B69-8657C97DCAE5Q36105634-5BAAF7C8-9F50-4BCF-957D-C34869ABA6ACQ36117690-95BAE73B-0C7D-4DA4-A961-3F37632A024BQ36252676-2AF91C28-50B6-4EA8-B68F-EFFAA0261D0BQ36647007-AE97DE49-BC79-4606-B7E9-E00DE462EEB7Q36755872-7FE04DD5-E831-4297-86A3-C3ECA60A646EQ36773744-716D14BA-B8DD-4194-B1CE-00E11FF8E48DQ36849117-A876F2FA-083A-452D-8F5B-C7EB52A2CE33Q37019841-D0625207-DC8E-4CA0-9F3E-3ECD8CFD6972Q37123377-B867A037-F99D-4A9D-8976-CD8A64BA03C0Q37149228-0AD97A27-EF5C-464A-ABAA-6F339EA44696Q37155632-1EEAE99D-EBB5-4EF2-8812-95AFDD6A9452Q37164443-0E87E954-6EEC-4F9E-9262-1FD137DC44E8Q37242239-FDB1267E-48F8-456C-9C06-AC87C86ABEA0Q37269654-36795CC3-340C-4D69-B3BA-30FE0D9775E0Q37290512-0684EC55-DBE2-448D-9B8C-FB0E4E48CB97Q37877648-D1CFF613-6EDB-4F91-9680-6B66503CC914
P2860
Clinical practice. Management of an inherited predisposition to breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical practice. Management of an inherited predisposition to breast cancer.
@en
type
label
Clinical practice. Management of an inherited predisposition to breast cancer.
@en
prefLabel
Clinical practice. Management of an inherited predisposition to breast cancer.
@en
P356
P1476
Clinical practice. Management of an inherited predisposition to breast cancer.
@en
P304
P356
10.1056/NEJMCP071286
P407
P577
2007-07-01T00:00:00Z